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DISCUSSION
Subarachnoid hemorrhage (SAH) can often be a 
devastating clinical diagnosis. The most common 
cause is a ruptured saccular cerebral aneurysm, 
with a reported 30-day fatality as high as 40% and 
permanent disability in 50% of the survivors [1]. This 
high morbidity and mortality can be partly explained 
by the high catecholamine surge resulting from 
SAH and its systemic effects, particularly to cardiac 
function [2]. The heart’s ability to maintain adequate 
hemodynamics and volume status is imperative for 
patient recovery. Reversible cardiac dysfunction is a 
well-known complication of subarachnoid hemorrhage. 
Arrhythmias, myocardial infarction, and cardiac arrest 
are well known complications in patients with SAH and 
can result in death and delayed cerebral ischemia [3-
5]. Rarely, SAH can also be associated with Takotsubo 
cardiomyopathy, which has a prevalence of 0.8% 
among all patients with aneurysmal SAH [6].
The development of Takotsubo cardiomyopathy (TCM), 
a transient dysfunction of the left ventricle which 
often mimics myocardial infarction, is increasingly 
recognized as a complication of SAH. TCM was first 
reported in Japan, when the peculiar ventricular 
morphology was noted to be quite similar in shape 
to the takotsubo, a vase with a rounded bottom and 
narrow neck used by Japanese fishermen as an 
octopus trap (Fig. 1). Patients with the syndrome 
show evidence of exacerbated sympathetic activation. 
TCM, while generally considered a self-limiting 
process, is important to recognize because it is 
associated with increased mortality rates resulting 
from the development of left ventricular thrombus, 
congestive heart failure (CHF), and arrhythmias [2]. It 
is a complication that is sometimes described in case 
reports and small case series.  It is generally agreed 
upon that conservative medical management is the 
mainstay of therapy for TCM, however no clinical trials 
to date exist to help guide treatment. This case report 
serves to introduce an example of SAH-induced TCM in 
order to raise awareness of this cardiac complication 
and the need for optimum clinical management. 
A Ruptured Basilar Aneurysm Resulting in Takotsubo Cardiomyopathy
Figure 1a: Ventriculography demonstrating takotsubo shape 
Figure 1b: A Japanese takotsubo jar, for which this syndrome derives its 
name.
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The prevalence of TCM is estimated to be 0.8% among all patients of aneurysmal SAH [6]. Many other TCM prevalence studies and meta-analyses in SAH patients do 
not distinguish between aneurysmal and non-aneurysmal causes. In a meta-analysis of 10 studies, 3581 patients were admitted with SAH, of which 157 patients were 
found to have developed TCM symptoms, representing 4.4% of the total patient population [9]. In another meta-analysis of over 53 papers, the incidence of TCM varied 
drastically from 0.8% to 33% [10]. 
Patients who develop SAH-induced TCM are shown to be at increased risk of worse outcomes. Patients with TCM were more likely to have moderate to severe 
subarachnoid bleeds (such as our patient) as measured by the Hunt and Hess classification [11]. There are significant increases of in-hospital mortality in patients 
that develop TCM [2, 9]. Patients with SAH-induced TCM are more likely to have low Glasgow coma scale scores [10]. SAH alone carries a significantly high mortality. 
Although TCM carries a favorable prognosis in the general population, this pattern of cardiac dysfunction in patients with SAH may be associated with pulmonary 
edema, prolonged intubation, and cerebral vasospasm, potentially further escalating risk of mortality [7). The pathophysiology behind the development of TCM in the 
setting of aneurysmal SAH still remains unclear, however high levels of catecholamine release is the most widely accepted theory. It is believe that this catecholamine 
surge can cause direct coronary vasospasm, which during a hypersympathetic state can lead to poor cardiac perfusion and dysfunction. There is also evidence for 
cathecholamines causing direct toxicity to the myocardium [2]. This superimposes additional challenges on the hemodynamic management of aneurysmal SAH 
patients in terms of optimal blood pressure and cerebral perfusion [7].  The use of vasopressors and inotropes remains controversial, as permissive hypertension is 
a key therapeutic goal in patients with SAH. While there is existing evidence that vasopressor agents can exacerbate TCM [8], more recent research suggests that 
vasopressors can be used safely [2]. 
In this case, the patient’s TCM was not discovered until after the patient underwent interventional therapy. This raises the question as to whether or not early cardiac 
screening with serial myocardial enzyme testing, EKGs and an echocardiogram should be standard studies for all SAH patients. Current American Heart Association 
Guidelines for the management of aneurysmal subarachnoid hemorrhage do not recommend routinely obtaining these studies during emergency evaluation and 
preoperative care, nor indicate to obtain these studies post-procedure [12]. Given that TCM may contribute to mortality in this population, potentially this change 
in protocol should be considered. However, further research is necessary, as there is a paucity of literature detailing whether early recognition of will lead to better 
outcomes. More evidence is also needed to help guide clinicians with therapeutic decision making in aneurysmal SAH patients with TCM, particularly with hemodynamic 
management, which remains a complicated endeavor as the incidence of this condition in the overall population is low.
A 75-year-old female with hyperlipidemia and no known coronary artery disease presented to the Emergency Department (ED) after suddenly 
grasping her head and collapsing onto the floor unconscious. 
On physical exam, she was afebrile, hypertensive with a blood pressure of 162/96 mmHg, pulse of 114 bpm and a respiration rate of 24. 
Cardiopulmonary exam was unremarkable. Neurologically she was unresponsive with Glascow Coma Score of 8, Hunt and Hess grade 4, Fisher 
4, and intubated for airway protection. Computer Tomography (CT) of her head revealed diffuse subarachnoid hemorrhage with intraventricular 
hemorrhage (Fig. 2). CT Angiography (CTA) demonstrated a 6.5 mm basilar tip aneurysm, and the patient underwent endovascular coil embolization 
(Fig. 3). After an initial screening troponin I of <0.02 ng/mL obtained during ED assessment, a second troponin I elevated to 1.43 ng/mL at the eleven 
hour mark and later down-trended to 0.90 ng/mL.  An echocardiogram showed mild to moderate reduction in left ventricular systolic function with 
severe hypokinesis of the apical segments. ( Fig. 4). Cardiology consultation was obtained. Given echocardiographic findings and clinical scenario, 
there was a suspicion for stress-induced (Takotsubo) cardiomyopathy. A recommendation was made to wean off the norepinephrine as this was likely 
exacerbating the catecholamine effect onto the heart. Repeat echocardiogram was performed 15 days later which showed complete resolution of 
prior left ventricular dysfunction and apical hypokinesis (Fig. 5).  As there was a clear improvement in cardiac function, an ischemic workup with a 
left heart catheterization was not warranted.  Neurologically, she made gradual improvements throughout her hospital stay. By the time of discharge 
to inpatient rehabilitation, she was alert, with improving speech, following commands, and moving all 4 limbs against gravity well. 
Figure 2: Intraventricular hemorrhage appreciated 
within the lateral ventricles bilaterally. Patient also had 
evidence of blood within the third and fourth ventricles. 
Figure 3: CTA with white arrow 
indicating 6.5 mm basilar tip 
aneurysm
Fig. 1bFig. 1a
Figure 4: Transthoracic echocardiogram two-chamber apical 
(mid-systole) demonstrating hypokinesis and “ballooning” of the 
left ventricular apex characteristic of takotstubo cardiomyopathy. 
Figure 5: Two-chamber apical view taken mid-systole 
demonstrating resolution of prior hypokinesis.
CONCLUSION
Since first being described in the literature, Takotsubo cardiomyopathy has become an increasingly recognized complication of SAH. It is an important diagnosis to 
consider as it can mimic an acute coronary syndrome and it can lead to more complications with treatment of SAH, particularly in the sub-population of SAH patients 
with aneurysms. Cardiac screening may be beneficial, however no clear guidelines are present to help guide therapeutic management. While outcomes are favorable 
with conservative therapy alone, there are still questions to be answered, particularly of the role vasopressors play in management. Awareness of this syndrome and 
reporting of it in the literature only serves to the betterment of medical therapies and patient outcomes.
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